New study finds common virus may improve skin cancer treatment outcomes
A new study led by the Fairfax Group at the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.
Read moreMRC Translational Immune Discovery Unit
Pioneering the future in the study of human immunity to uncover the molecular pathways driving immune-mediated diseases.
MRC Molecular Haematology Unit
Understanding how mature blood cells are normally made from stem cells and how this is perturbed in common blood disorders.
Centre for Computational Biology
Using computational biology to help understand complex biological systems and combat a range of human diseases.
Latest publications
-
Perturbing LSD1 and WNT rewires transcription to synergistically induce AML differentiation
Hosseini A. et al, (2025), Nature
-
Is Enhancer Function Driven by Protein-Protein Interactions? From Bacteria to Leukemia.
Crump NT. and Milne TA., (2025), Bioessays
-
DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibition.
Ayyadevara VSSA. et al, (2025), Leukemia
-
BCL11B-related disease: a single phenotypic entity?
Vedovato-dos-Santos JH. et al, (2025), European Journal of Human Genetics
-
Magrolimab plus azacitidine vs physician's choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 study.
Zeidner JF. et al, (2025), Blood
Upcoming Seminars
-
Wednesday, 30 April 2025, 1.30pm to 2.30pm
Speakers: Dr Andreas Wack
-
Thursday, 01 May 2025, 12pm to 1pm
Speakers: Professor Adrian Liston
-
Friday, 02 May 2025, 10.45am to 11.45am
Speakers: Hannah Long
-
Tuesday, 06 May 2025, 1pm to 2pm
Speakers: Professor Cristina Lo Celso
-
Thursday, 08 May 2025, 12pm to 1pm
Speakers: Dr Raheleh Rahbari